Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primed PBSC Transplant for Lymphoma
NCT00005985Phase 2Completed
- Sponsor
- Masonic Cancer Center
- Start
- Aug 2000
- Primary completion
- Feb 2007
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of filgrastim in Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), sponsored by Masonic Cancer Center. Started Aug 2000; status: completed.
02
Drugs
filgrastim
03
Conditions
Hodgkin lymphoma (HL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00005985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005985.